Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Impact of palmitic acid-enriched supplement on pancreatic cancer (PANC-1) and its antimicrobial potential

Nahed Ahmed Hussien1 , Ehab M Tantawy2

1Department of Biology, College of Science, Taif University, Taif 21944, Saudi Arabia; 2Research and Development Sector, EGYVAC, VACSERA, Giza 12311, Egypt.

For correspondence:-  Nahed Ahmed Hussien   Email: n.nahed@tu.edu.sa

Received: 17 December 2024        Accepted: 12 March 2025        Published: 30 March 2025

Citation: Hussien N, Tantawy EM. Impact of palmitic acid-enriched supplement on pancreatic cancer (PANC-1) and its antimicrobial potential. Trop J Pharm Res 2025; 24(3):311-321 doi: 10.4314/tjpr.v24i3.3

© 2025 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the anti-pancreatic cancer and antimicrobial effects of fat-enriched dietary supplements (FEDS). Method: Gas chromatography-mass spectrometry (GC-MS) was used to screen FEDS components. The FEDS cytotoxicity (SRB) was assessed using mouse endothelial (non-cancerous, C-166 normal cells) and pancreatic cancer line (PANC-1). Antimicrobial evaluation of FEDS was conducted against different microbial strains to obtain the minimum inhibitory (MIC) and bactericidal (MBC) concentrations. Results: Gas chromatography-mass spectrometry (GC-MS) revealed that the predominant fatty acid found in the present supplement is palmitic acid (< 75 %), followed by α-linoleic acid (7.39 %), stearic acid (5.76 %), and other polyunsaturated fatty acids (≤ 2 %). The FEDS exhibited a dose-dependent, low cytotoxic effect (0.001 -100 μg/mL) against PANC-1 pancreatic cancer cells (IC50 > 100 μg/mL) and C-166 (IC50 = 164.71). A high PA-palmitic acid-enriched supplement shows antifungal and mild antibacterial potential against common strains that contribute to pancreatic cancer development. Candida albicans, Gram-positive (Bacillus cereus, Enterococcus faecalis, and Staphylococcus aureus), and Gram-negative (Escherichia coli) strains showed MIC and MBC > 1000 μg/mL. Conclusion: This finding highlights the complex interplay between dietary fats, cytotoxicity, and antimicrobial activity in pancreatic cancer. Future studies should focus on the specific roles of different fatty acids and their interactions with the tumor microenvironment to develop targeted nutritional strategies that may improve survival and quality of life for individuals affected by pancreatic ductal adenocarcinoma (PDA).

Keywords: Palmitic acid, PANC-1, Pancreatic cancer, C-166, Antimicrobial, Cytotoxicity

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2025; 24: 
1,   2,   3
2024; 23: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates